The outcome of IHE initiatives is providing better information for developing health policy and best medical practices. IHE disseminates information in many ways. In addition to publications in peer-reviewed journals, IHE produces books and a variety of reports synthesizing information in a particular field.
If you cannot find the publication or report you are seeking, please contact us at info@ihe.ca. Thank you!
Refine your search by clicking filters to the left.
Rationale, aims and objectives: The Appraisal of Guidelines Research and Evaluation (AGREE) instrument is a generic tool for assessing guideline quality. This feasibility study aimed to reduce the ambiguity and subjectivity associated with AGREE item scoring, and to augment the tool's capacity to differentiate between good- and poor-quality guidelines. Note: This is an Alberta…
1 December 2009Edmonton, Alberta Welcome and Opening Remarks Lorne Tyrrell, Chair of the Institute of Health Economics Fred Horne, Chair, Standing Policy Committee on Health Speakers / Keynote Presentations Robert Brook, Rand HealthDownload Presentation Jeff Lozon, CEO Revera LivingDownload Presentation Presentations & Panel discussion Stephen Duckett, CEO, Alberta…
Speaker Biographies Keynote Speakers Dr. Robert Brook Dr. Robert Brook, M.D., Sc.D., F.A.C.P is Vice-President and Director of RAND Health, Professor of Medicine at the David Geffen School of Medicine and Professor of Health Services at the School of Public Health at the University of California, Los Angeles, where he also directs the Robert Wood Johnson Clinical Scholars Program.…
1 December 2009 Edmonton, Alberta Emceed by Tom Feasby, the University of Calgary’s Dean of Medicine, this third session considered the following theme: Maximizing Health System Performance: Cost Containment and Improved Efficiency. Speakers from all sectors provided a range of perspectives on Cost Containment and Improved Efficiency Key Forum Documents Innovation Forum III…
Emceed by Tom Feasby, the University of Calgary’s Dean of Medicine, this third session considered the following theme: Maximizing Health System Performance: Cost Containment and Improved Efficiency. Speakers from all sectors provided a range of perspectives on Cost Containment and Improved Efficiency.
PDF of a PowerPoint presentation by Dr. Robert Brook, Rand Health. IHE Innovation Forum III - Maximizing Health System Performance (1): Cost Containment and Improved Efficiency
PDF of a PowerPoint presentation by Mr. Jeff Lozon, CEO Revera Living. IHE Innovation Forum III - Maximizing Health System Performance (1): Cost Containment and Improved Efficiency
PDF of a PowerPoint presentation by Dr. Stephen Duckett, CEO, Alberta Health Services. IHE Innovation Forum III - Maximizing Health System Performance (1): Cost Containment and Improved Efficiency
PDF of a PowerPoint presentation by Dr. Dr. Philip Baker, Dean of Medicine, University of Alberta. IHE Innovation Forum III - Maximizing Health System Performance (1): Cost Containment and Improved Efficiency
The Consensus Statement on Fetal Alcohol Spectrum Disorder (FASD) - Across the Lifespan was produced by a panel of experts led by the Hon. Anne McLellan, former Deputy Prime Minister of Canada. This consensus statement on fetal alcohol spectrum disorder is the product of a unique conference: The IHE Consensus Development Conference on Fetal Alcohol Spectrum Disorder - Across the…
Le présent énoncé consensuel a été préparé par un panel indépendant de professionnels de la santé et de représentants du milieu universitaire et du public en se fondant sur: les études publiées pertinentes réunies par le Comité scientifique de la conférence pour l’établissement…
PDF of a PowerPoint presentation by Ms. Nancy Whitney, Clinical Director, King County Parent-Child Assistance Program, University of Washington. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Amy Salmon, Managing Director, Canada Northwest FASD Research Network; Clinical Assistant Professor, School of Population and Public Health, Faculty of Medicine, University of British Columbia. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Frank Oberklaid, Director, Centre for Community Child Health, Royal Children's Hospital, and Professor, Pediatrics, University of Melbourne. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Audrey McFarlane, Executive Director, Lakeland Centre for Fetal Alcohol Spectrum Disorder. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Elizabeth Bredberg, Education Consultant, Bredberg Research and Consulting in Education. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Claire Coles, Professor, Department of Psychiatry and Behavioral Sciences and Pediatrics, Emory University School of Medicine; Director, Fetal Alcohol and Drug Exposure Clinic, Marcus Autism Center, Children's Health Care of Atlanta. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Brenda Bennett, Executive Director, FASD Life's Journey Inc. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Prof. Sharon Brintnell, Professor, Department of Occupational Therapy, and Director, Occupational Performance Analysis Unit, Faculty of Rehabilitation Medicine, University of Alberta. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. John McLennan, Assistant Professor and Child Psychiatry Consultant, Departments of Community Health Sciences, Psychiatry, and Paediatrics, University of Calgary. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by the Honourable Mary Kate Harvie, Associate Chief Judge, Provincial Court of Manitoba. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Dorothy Badry, Assistant Professor, Faculty of Social Work, University of Calgary. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Sterling Clarren, CEO and Scientific Director, Canada Northwest FASD Research Network; Clinical Professor of Pediatrics, Faculty of Medicine, University of British Columbia; Clinical Professor of Pediatrics, University of Washington School of Medicine. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the…
PDF of a PowerPoint presentation by Dr. Sara Jo Nixon, Professor, Department of Psychiatry, University of Florida, Clinical and Translational Science Institute, Biobehavioral Core. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Nancy Poole, Research Associate, British Columbia Centre of Excellence for Women's Health; Research Consultant, Women and Substance Use Issues, British Columbia Women's Hospital. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
7 – 9 October 2009 Edmonton, Alberta Alcohol can hurt the brain and body of an unborn baby and cause Fetal Alcohol Spectrum Disorder (FASD), a serious lifelong condition that impacts both the individual and their family. A child with FASD becomes an adult with FASD, facing birth defects, developmental and learning delays and social, educational, and employment challenges.…
Speakers | Jury | Scientific Committee | Planning Committee | Communications Committee Chair Dr. Gail Andrew, MDCM FRCP(C) Member, Board of Directors, Canada Northwest FASD Research Network; Medical Site Lead - Pediatrics, Medical Director - FASD Clinical Services and Pediatric Consultant, Pediatric Programs, Glenrose Rehabilitation Hospital Speakers Susan Astley, PhD Professor…
Wed 7 Oct 2009 | Thu 8 Oct 2009 | Fri 9 Oct 2009 Fetal Alcohol Spectrum Disorder (FASD) – Across the Lifespan – Final Program Conference Moderator: Nancy Reynolds, President and Chief Executive Officer, Alberta Centre for Child, Family and Community Research Wednesday, 7 October 2009 08:00 – 08:20 Opening Remarks The Honourable Iris Evans, Minister of Finance…
Program Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD) – Across the Lifespan – Final Program Download Program Consensus Statement Consensus Statement on Fetal Alcohol Spectrum Disorder – Across the Lifespan Download Consensus Statement Déclaration de consensus sur l’ensemble des troubles causés…
PDF of a PowerPoint presentation by Dr. Gail Andrew, Member, Board of Directors, Canada Northwest FASD Research Network; Medical Site Lead - Pediatrics, Medical Director - FASD Clinical Services and Pediatric Consultant, Pediatric Programs, Glenrose Rehabilitation Hospital. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Suzanne Tough, Scientific Director, Alberta Centre for Child, Family and Community Research. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Philip May, Professor of Sociology and Family and Community Medicine, University of New Mexico; Senior Research Scientist, Center on Alcoholism, Substance Abuse, and Addictions. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Ben Gibbard, Developmental Pediatrician, Alberta Children's Hospital; Assistant Professor, Department of Pediatrics, Faculty of Medicine, University of Calgary. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Susan Astley, Professor of Epidemiology/Pediatrics, University of Washington; Director, Washington State Fetal Alcohol Syndrome Diagnostic and Prevention Network. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Albert Chudley, Medical Director, Winnipeg Regional Health Authority Program in Genetics and Metabolism; Professor, Department of Pediatrics, University of Manitoba. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Joanne Weinberg, Professor and Distinguished University Scholar and Acting Department Head, Cellular and Physiological Sciences, University of British Columbia. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Phil Jacobs, Professor, Gastroenterology Division, Department of Medicine, University of Alberta; Director of Collaborations, Institute of Health Economics. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Mary Berube, Director, Intergovernmental Initiatives, Ministry Support Services Division, Alberta Children and Youth Services. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. Linda Burnside, Executive Director, Disability Programs, Manitoba Family Services and Housing. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Mr. Dan Dubovsky, FASD Specialist for the Substance Abuse and Mental Health Services Administration (SAMHSA), FASD Center for Excellence. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Diane Malbin, Executive Director, Fetal Alcohol Syndrome Consultation, Education and Training Services. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Ms. Robin Thurmeier, FASD Resources Researcher, Saskatchewan Prevention Institute. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
PDF of a PowerPoint presentation by Dr. June Bergman, Associate Professor, Department of Family Medicine, Faculty of Medicine and Dentistry, University of Calgary. Consensus Development Conference on Fetal Alcohol Spectrum Disorder (FASD): Across the Lifespan
Alcohol can hurt the brain and body of an unborn baby and cause Fetal Alcohol Spectrum Disorder (FASD), a serious lifelong condition that impacts both the individual and their family. A child with FASD becomes an adult with FASD, facing birth defects, developmental and learning delays and social, educational, and employment challenges. The IHE Consensus Development Conference on…
Written by health policy experts, the book gives a comprehensive overview of 8 different national health care systems and focuses in particular on the different approaches to maintain efficiency and to contain overall healthcare costs. Each chapter identifies the 4-5 specific policies with the highest impact for the respective country over the past 20-30 years and the current policy…
Speaker Biographies Speakers Dr. Stephen Duckett Dr. Stephen Duckett has spent his professional life working in health care. As Alberta Health Services' new President and Chief Executive Officer (effective March 23, 2009). He has more than 35 years of experience in health care. Prior to coming to Alberta, Dr. Duckett was Chief Executive Officer of the Centre for Healthcare Improvement…
25 May 2009Edmonton, Alberta Welcome and Introductions Lorne Tyrrell, Chair of the Board Institute of Health Economics, Professor and CIHR/GSK Virology Chair, University of Alberta Fred Horne, MLA, Chair, Standing Committee on Health, Alberta Ken Hughes, Board Chair, Alberta Health Services Presentations Generating evidence to inform difficult decisions: building capacity through…
25 May 2009 Edmonton, Alberta The Institute of Health Economics (IHE) Innovation Forum series reflects one of the key goals of the Institute to promote open debate and dialogue on important issues in the health care system among academia, government, health service executives and industry. The Institute believes that the significant challenges facing the health system will only…
The Institute of Health Economics (IHE) Innovation Forum series reflects one of the key goals of the Institute to promote open debate and dialogue on important issues in the health care system among academia, government, health service executives and industry. The Institute believes that the significant challenges facing the health system will only be addressed if all partners…
PDF of a PowerPoint presentation by Dr. Chris Henshall, Pro-Vice Chancellor, York University, UK. IHE Innovation Forum II - Making Difficult Decisions
PDF of a PowerPoint presentation by Sir Michael Rawlins, Chairman of National Institute of Clinical Excellence, UK. IHE Innovation Forum II - Making Difficult Decisions
PDF of a PowerPoint presentation by Mr. Gregg Szabo, Executive Director, Policy, Reimbursement & Communicationa, Merck Frosst Canada Ltd. IHE Innovation Forum II - Making Difficult Decisions
PDF of a PowerPoint presentation by Dr. Stephen Duckett, President and CEO, Alberta Health Services. IHE Innovation Forum II - Making Difficult Decisions
The objective of this report is to assess research evidence on the safety and prognostic value of exercise testing (including electrocardiogram exercise testing and cardiopulmonary exercise testing) for the prediction of cardiac events in patients with chronic diseases including diabetes, chronic obstructive pulmonary disease (COPD), and arthritis. Information Specialist: Trish…
Alberta STE Report written under contract with the Alberta Health Technologies Decision Process (AHTDP). This report is about testing for Human Papillomavirus (HPV). HPV is one of the most common sexually transmitted infections and can also cause cervical cancer. Cervical screening aims to reduce cervical cancer incidence and mortality by detecting precancerous lesions early. Until…
Les estimations indiquent que un canadien sur trois aura un problème de santé mentale durant sa vie. Peu de canadiens réalisent l’impact que la mauvaise santé mentale a sur les familles, les communautés, les systèmes de santé et l’économie. La santé mentale est aussi importante que la santé physique…
This report provides information regarding the impact of physician reimbursement models on five dimensions specified in the Provincial Alternate Relationship Plan Program Evaluation. The impact of physician reimbursement models were assessed on the following five dimensions: Health service utilization Access to care Quality of services Patient satisfaction Physician satisfaction…
The use of the term “comparative effectiveness” (CE) has attracted considerable attention, particularly in the United States. This booklet examines the concept of CE and its relationship to other assessment frameworks.
Background: Although many programs targeting fetal alcohol spectrum disorder (FASD) are implemented, the province of Alberta is still lacking information on costs of FASD. Objectives: To estimate the costs of FASD in Alberta based on available US and Canadian research on costs of FASD, and Alberta data.
The purpose of this report is to advance the area of workplace mental health through a comprehensive synthesis of published research evidence. More specifically, this report examines the evidence on the effectiveness of organizational-level interventions for the prevention of stress in the workplace for adult employees without diagnosed mental illness. The main effectiveness outcomes…
This report on assisted reproductive technologies (ARTs) is a literature review and secondary analyses of administrative health data conducted to provide information on the direct health care costs associated with multiple pregnancies and the potential cost impact of ARTs in Alberta. It examines the impact of multiple pregnancies and Assistive Reproductive Technologies on health…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #23. This report is intended as a discussion primer for two challenges increasingly faced by health technology assessment (HTA), health impact assessment (HIA), health needs assessment, parliamentary technology assessment (PTA), participatory technology assessment, policy makers in numerous areas, health care…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #21. Much of the activity and purpose of HTA is related to interaction with organizations and individuals with interests in the technologies that are being considered. The focus is often stakeholders with major financial or operational responsbilities for health technologies, including government authorities,…
Institute of Health Economics Working Paper WP 05-07. The aim of this paper is to compare health in Canada and the United States using a preference-based measure. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior to 2006 have different formats; the format was determined by the agency for which the document…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #36. The objective of this report is to identify the most appropriate investigative protocol, or component of a protocol, for determining the cause(s) of stillbirth and to identify protocols that have been recommended by health authorities and professional associations both within Canada and worldwide. Information…
Institute of Health Economics Working Paper WP 05-03. Missing data is a common problem in studies that collect data on patient-reported outcomes data. This paper reports the methods, results, and an evaluation of one method for imputing missince Centre for Epidemiological Studies-Depression (CES-D) data in a study of health-related quality of life (HRQL) in a cohort of patients…
Institute of Health Economics Working Paper WP 05-06. The purpose of this study was to analyze epidemiologic and cost trends from 1991 to 2001 in the province of Saskatchewan for a cohort of individuals identified as having diabetes and for a randomly selected control cohort. The objectives were to: explore epidemiologic trends (i.e., prevalence, incidence and mortality) in diabetes…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #18. This paper has two specific objectives: to describe some of the challenges of using research evidence to inform healthcare policy making; and to provide policy makers and researchers with a framework or tool that would identify and facilitate the use of research evidence and other information in healthcare…
Institute of Health Economics Working Paper WP 05-02. The purpose of this report was to assess the cross-sectional construct validity of the Health Utilities Mark 3 (HUI3) in type 2 diabetes using population-health survey data. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior to 2006 have different formats;…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #17. This paper focuses on incident reporting systems relevant to the hospital and efforts to improve patient safety and clinical outcomes. Costs associated with incident reporting systems are included wherever possible. This paper aims to assess the effectiveness of hospital incident reporting systems in improving…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #26. The aim of this study was to determine whether laparoscopic adjustable gastric banding (LAGB) is a safe and effective procedure compared with open and/or laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic vertical banded gastroplasty (LVBG), especially in the longer term (> or = five…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #25. The aim of this report is to provide a cost estimate, over a one year time period from a payer’s perspective, of Biosite Triage Point-of-Care (POC) B-Type Natriuretic Peptide (BNP) assay used to rule out congestive heart failure (CHF) from other pulmonary conditions for patients presenting in…
Institute of Health Economics Working Paper WP 05-01. The objective of this paper is to assess a broad range of determinants of health to determine which are most strongly associated with health-related quality of life (HRQL) in people with type 2 diabetes. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #24. The objective of this paper is to present the current evidence on the efficacy/effectiveness and safety of celeoxib (Celebrex®) for the treatment of pain in patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Information Specialist: Seana Collins NOTE: In 2006 the Alberta Heritage Foundation…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Initiative #19. The intent is to develop an overview as a guide to HTA managers; this paper should be regarded as a vehicle for further discussion on these issues. NOTE: In 2006 the Alberta Heritage Foundation for Medical Research HTA unit moved to IHE. Documents produced in and prior to 2006 have different formats; the…
Alberta Heritage Foundation for Medical Research (AHFMR) Information Paper #23. The activities of the HTA Unit in 2002–2003, as reflected in various types of reports it had produced and related dissemination activities, were reviewed in a paper published in 2004. The paper provided an overview of the effectiveness of the Unit as an aid to its future management, drawing on…
Alberta Heritage Foundation for Medical Research (AHFMR) HTA Report #35. The objective of this report is to assess the efficacy and safety of using trigger point injection (TPI) to treat patients with chronic non-malignant musculoskeletal pain, based on a systematic review of the current published evidence, and to determine the current state of the procedure, the feasibility of…
